Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Charlottesville, VA
SEC filing record 1 source field available
Fiscal year end
31 December
ADIAL PHARMACEUTICALS, INC. has filed 562 SEC EDGAR filings since 16 Mar 2011

SEC filing history

Showing 76-100 of 562 matching filings.

Per page
25
Current page
4
CORRESP

CORRESP filing

Filing date
12 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
12 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-38323

FORM ARS

Filing date
10 Jun 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38323

PROXY STATEMENT

Filing date
10 Jun 2025
Reporting date
24 Jul 2025
Next action
Verify source filing
424B3 File 333-287679

PROSPECTUS

Filing date
10 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-287679

EFFECT filing

Filing date
09 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
06 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-287826

REGISTRATION STATEMENT

Filing date
06 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
05 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-287679

UPLOAD filing

Filing date
04 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Jun 2025
Reporting date
29 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Jun 2025
Reporting date
29 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Jun 2025
Reporting date
29 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Jun 2025
Reporting date
29 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Jun 2025
Reporting date
29 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Jun 2025
Reporting date
29 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Jun 2025
Reporting date
29 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-287679

REGISTRATION STATEMENT

Filing date
30 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
30 May 2025
Reporting date
23 May 2025
Next action
Verify source filing
PRE 14A File 001-38323

PROXY STATEMENT

Filing date
23 May 2025
Reporting date
23 May 2025
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
15 May 2025
Reporting date
15 May 2025
Next action
Verify source filing
10-Q File 001-38323

QUARTERLY REPORT

Filing date
14 May 2025
Reporting date
31 Mar 2025
Next action
Verify source filing
D File 021-546005

D filing

Filing date
14 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
07 May 2025
Reporting date
02 May 2025
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .